John Boyer Inc’s AbbVie ABBV Stock Holding History

John Boyer Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$827K	Buy	3,287 +30	+0.9%	+$6.45K	0.72%	22
2026 Q1	$709K	Buy	3,257 +23	+0.7%	+$5.1K	0.71%	21
2025 Q4	$739K	Buy	3,234 +15	+0.5%	+$3.42K	0.75%	21
2025 Q3	$745K	Buy	+3,219	New	+$656K	0.74%	21

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Boyer Inc's ABBV Position: Q2 2026 in Review

John Boyer Inc increased its AbbVie (ABBV) stake by 0.92% in Q2 2026, buying an estimated $6.45K and bringing the position to 3,287 shares worth $827K. The position accounts for 0.72% of the portfolio, ranked #22.

John Boyer Inc first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

John Boyer Inc held 3,287 shares of AbbVie worth $827K as of Q2 2026.
John Boyer Inc bought 30 AbbVie shares in Q2 2026, an estimated $6.45K.
AbbVie made up 0.72% of John Boyer Inc's portfolio in Q2 2026, its #22 holding.
John Boyer Inc first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on John Boyer Inc's 13F filing for Q2 2026, filed 7 Aug 2026.